These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 7523566)
1. The essence of epitopes. Barber LD; Parham P J Exp Med; 1994 Oct; 180(4):1191-4. PubMed ID: 7523566 [No Abstract] [Full Text] [Related]
2. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300 [TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides anchor T cell-specific TNP epitopes to MHC antigens. Ortmann B; Martin S; von Bonin A; Schiltz E; Hoschützky H; Weltzien HU J Immunol; 1992 Mar; 148(5):1445-50. PubMed ID: 1371527 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. Maecker HT; Umetsu DT; DeKruyff RH; Levy S J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678 [TBL] [Abstract][Full Text] [Related]
5. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572 [TBL] [Abstract][Full Text] [Related]
6. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Jameson SC; Bevan MJ Eur J Immunol; 1992 Oct; 22(10):2663-7. PubMed ID: 1396971 [TBL] [Abstract][Full Text] [Related]
7. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986. Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ J Immunol; 2006 May; 176(9):5141-50. PubMed ID: 16621977 [No Abstract] [Full Text] [Related]
8. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815. Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302 [TBL] [Abstract][Full Text] [Related]
9. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones. Deckhut AM; Tevethia SS J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447 [TBL] [Abstract][Full Text] [Related]
10. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734 [TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocytes against a soluble protein. Staerz UD; Karasuyama H; Garner AM Nature; 1987 Oct 1-7; 329(6138):449-51. PubMed ID: 2443853 [TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. Carbone FR; Moore MW; Sheil JM; Bevan MJ J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012 [TBL] [Abstract][Full Text] [Related]
14. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754 [TBL] [Abstract][Full Text] [Related]
15. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. Porgador A; Gilboa E J Exp Med; 1995 Jul; 182(1):255-60. PubMed ID: 7540653 [TBL] [Abstract][Full Text] [Related]
17. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214 [TBL] [Abstract][Full Text] [Related]
18. Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees. Kowalski H; Erickson AL; Cooper S; Domena JD; Parham P; Walker CM J Exp Med; 1996 Apr; 183(4):1761-75. PubMed ID: 8666933 [TBL] [Abstract][Full Text] [Related]
19. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675 [TBL] [Abstract][Full Text] [Related]
20. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). da Silva J; Hughes AL Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]